I
I

Intel

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Intel seeks $10 bln in subsidies for European chip plant

* Intel CEO meeting EU's Breton to discuss semiconductors * EU looking to 'drastically increase' chip production * Intel CEO eyes Germany, Benelux for potential plant * TSMC stresses commitment to Europe after Breton talks * Breton meets ASML, NXP bosses next week - Commission By Douglas Busvine BRUSSELS/BERLIN, April 30 (Reuters) - Intel INTC.O wa
B
D
I
I
N
V
A

EU explores chipmaker alliance as alternative to foreign-funded megafab - sources

By Mathieu Rosemain, Michel Rose and Foo Yun Chee PARIS/BRUSSELS, April 29 (Reuters) - The European Union is considering creating a semiconductor alliance including STMicroelectronics, NXP, Infineon and ASML to cut dependence on foreign chipmakers amid a global supply chain crunch, four EU officials said. The plan, which is at a very preliminary st
A
I
I
N
A

Activist investors post strong returns with board campaigns in first quarter

By Svea Herbst-Bayliss BOSTON, April 29 (Reuters) - Activist investors have been outperforming their peers and the broader market this year by pushing for board-room changes rather than dramatic business overhauls, breakups or mergers, according to performance data and industry sources. The average activist hedge fund returned 8.76% in the first qu
I
U

STMicro advances key sales target by two years on booming chip demand

* Q1 beat market expectations * Group targets $12 bln sales in 2021 * Beefs up investments to meet demand By Mathieu Rosemain PARIS, April 29 (Reuters) - Franco-Italian chipmaker STMicroelectronics STM.PA advanced by two years a target of $12 billion in annual sales as a wave of orders swept the semiconductor industry to cause a global shortage tha
A
I
T
V

From Amazon to Tata, industry steps up to combat India's coronavirus crisis

By Nivedita Bhattacharjee, Chris Thomas and Sachin Ravikumar BENGALURU, April 28 (Reuters) - Global and Indian firms are flexing their industrial muscle to help the world's second biggest population battle coronavirus, coming to the rescue of a public health system buckling under the weight of surging infections and deaths. Amazon.com AMZN.O , Inte
A
G
I

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.